From Nasdaq: 2025-03-28 18:15:00

Zoetis (ZTS) closed at $163.11, down 1.16% from the previous day, outperforming S&P 500. Earnings report expected on May 6, 2025, with projected EPS of $1.41 and revenue of $2.19 billion. Recent analyst estimate changes indicate positivity and potential stock price impact. Zoetis currently has a Zacks Rank of #4 (Sell).

Zoetis trades at a Forward P/E ratio of 27.15, higher than the industry average of 15.51. PEG ratio is 2.91 compared to industry’s 1.06. Medical – Drugs industry ranks in the top 31% of all industries. Zacks Industry Rank shows top-rated industries outperform bottom half by 2 to 1. Watch Zacks.com for stock-influencing metrics.

Zacks Research Chief identifies the stock most likely to double in the coming months. Sheraz Mian highlights a top pick in the financial sector with innovative solutions and a growing customer base. Zacks’ previous stock picks have shown impressive gains. Access top stock recommendations from Zacks Investment Research for free.



Read more at Nasdaq: Zoetis (ZTS) Stock Moves -1.16%: What You Should Know